OGEN
Oragenics·AMEX
--
--(--)
--
--(--)
2.94 / 10
Underperform
Fundamental analysis shows Oragenics with a low 2.94/10 score, primarily due to sub-par Days Sales Outstanding (72.55 days) and negative Revenue-MV (-0.257). Strengths include a solid Interest Coverage Ratio (15.48) and high Operating Revenue YoY growth (92.66%). However, the negative factors outweigh the positives, leading to an overall weak fundamental stance and a cautionary investment view.
Analysis Checks(7/10)
Revenue-MV
Value-0.26
Score3/3
Weight20.57%
1M Return10.54%
Value-0.26
Score3/3
Weight20.57%
1M Return10.54%
Days sales outstanding
Value72.55
Score1/3
Weight-2.26%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.26%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight16.41%
1M Return8.45%
Value-0.17
Score2/3
Weight16.41%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.64%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.64%
1M Return-1.11%
Asset-MV
Value-0.50
Score1/3
Weight12.00%
1M Return6.68%
Value-0.50
Score1/3
Weight12.00%
1M Return6.68%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.76%
1M Return1.11%
Value78.47
Score2/3
Weight1.76%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight16.40%
1M Return8.45%
Value0.46
Score2/3
Weight16.40%
1M Return8.45%
PB-ROE
Value1.16
Score1/3
Weight19.97%
1M Return9.57%
Value1.16
Score1/3
Weight19.97%
1M Return9.57%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.68%
1M Return0.43%
Value92.66
Score2/3
Weight0.68%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight16.12%
1M Return8.41%
Value-0.07
Score2/3
Weight16.12%
1M Return8.41%
Revenue-MV
Value-0.26
Score3/3
Weight20.57%
1M Return10.54%
Value-0.26
Score3/3
Weight20.57%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.76%
1M Return1.11%
Value78.47
Score2/3
Weight1.76%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-2.26%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.26%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight16.40%
1M Return8.45%
Value0.46
Score2/3
Weight16.40%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight16.41%
1M Return8.45%
Value-0.17
Score2/3
Weight16.41%
1M Return8.45%
PB-ROE
Value1.16
Score1/3
Weight19.97%
1M Return9.57%
Value1.16
Score1/3
Weight19.97%
1M Return9.57%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.64%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.64%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.68%
1M Return0.43%
Value92.66
Score2/3
Weight0.68%
1M Return0.43%
Asset-MV
Value-0.50
Score1/3
Weight12.00%
1M Return6.68%
Value-0.50
Score1/3
Weight12.00%
1M Return6.68%
Cash-MV
Value-0.07
Score2/3
Weight16.12%
1M Return8.41%
Value-0.07
Score2/3
Weight16.12%
1M Return8.41%
Is OGEN undervalued or overvalued?
- OGEN scores 2.94/10 on fundamentals and holds a Premium valuation at present. Backed by its -157.09% ROE, 0.00% net margin, -0.28 P/E ratio, 0.31 P/B ratio, and 118.14% earnings growth, these metrics solidify its Underperform investment rating.
